Food & Beverage
What's Happening in Food & Beverage
GLP-1 weight-loss drugs are reshaping consumer spending and food markets through two distinct channels. Pharmaceutical adoption is expanding rapidly—Novo Nordisk's oral Wegovy formulation is outperforming projections and Eli Lilly raised full-year guidance on accelerating Zepbound and Mounjaro sales, while Lilly's Foundayo added sleep apnea as a secondary indication to broaden insurance coverage and patient demand. This pharmaceutical momentum is fragmenting the food and nutrition market: supplement makers like Novonesis are positioning vitamins and protein as adjuncts to GLP-1 treatment to offset deficiencies from reduced food intake, creating a new revenue stream tied to drug adoption rather than competing with it. Simultaneously, employer cost pressures are shifting GLP-1 coverage away from group plans toward out-of-pocket and direct-to-consumer channels, which alters both pharmaceutical margins and consumer spending patterns in weight loss. UK retail is contracting structurally as consumer discretionary spending weakens and shopping behavior shifts online, forcing traditional chains into omnichannel strategies or insolvency: Poundland faces potential collapse with 12,000 jobs at risk, Primark is accelerating home delivery launches, and Asda recruited a new chief executive to strengthen competitive position, while discount retailers and charity shops report margin compression and lost sales to online resale platforms. Defensive consumer behavior is also emerging—retailers report surges in canned and radio purchases following official stockpiling warnings, indicating precautionary spending is offsetting weakness in discretionary categories. These pressures reinforce each other: GLP-1 adoption reduces food consumption among a growing patient base, UK retail weakness reflects both structural online migration and cost-of-living constraints on discretionary spending, and employer pullback on drug coverage shifts financial burden to consumers already under spending pressure.
Packaged food, beverages, and food manufacturing companies spanning both staple and discretionary consumption.
47 events touching this theme
- Single sourceMARKET SHOCK ↓about 1 month agoUK Retail Restructuring
Greggs eliminating 740 positions and shuttering four production facilities
The bakery chain will close four factories and eliminate 740 jobs as it navigates cost pressures in UK food retail.
BBC News
- Single sourceabout 24 hours agoGLP-1 Drug Market
Ro's revenue surges tenfold after embracing GLP-1 weight-loss drugs
Ro, a telehealth platform, revived its business through GLP-1 drug offerings and operational restructuring.
The New York Times
- Single source3 days agoGLP-1 Drug Development
Eli Lilly's Foundayo reduces sleep apnea in late-stage testing
Eli Lilly will seek U.S. approval by year-end for its daily obesity pill to treat moderate-to-severe obstructive sleep apnea in obese adults.
CNBC
- Single source3 days agoGLP-1 Drug Market
Novonesis pursues gut-health supplements for obesity medication users
Supplement makers see market opening as GLP-1 drugs reshape weight-loss category.
CNBC
- Single source4 days agoPublic Health & Food Policy
Duck mascot becomes face of D.C. foie gras prohibition
Washington D.C. banned foie gras production and sale, driven partly by animal welfare advocacy.
The New York Times
- Single source4 days agoConsumer Brands & Retail
Poppi founders launch Jetty hydration brand to challenge Gatorade
Poppi founders launch Jetty, a new beverage brand competing directly against PepsiCo's Gatorade.
CNBC
- Single source6 days agoFood & Nutrition Policy
Post-Brexit food deal threatens naming rules for bacon-flavored crisps
UK smoky bacon crisp flavoring reignites dispute over EU food additive rules post-Brexit.
BBC News
- Single source6 days agoConsumer Brands & Retail
M&S muscles in on Christmas ad wars with shredded Santa
Marks & Spencer launches provocative Christmas ad featuring shirtless Santa to compete with John Lewis seasonal campaign.
The Guardian
- Single source7 days agoConsumer Brands & Retail
Costco approaches May peak as recovery accelerates
Costco approaches its May record high as the retailer gains momentum.
CNBC
- Single source8 days agoConsumer Brands & Retail
Cosmetics maker raises annual forecast after 51% revenue jump
E.l.f. Beauty reports 51% sales growth and raises full-year guidance, signaling strong demand in cosmetics retail.
CNBC
- Single source8 days agoUK Retail Restructuring
Poundland suppliers urge UK to block owner's profit extraction
Poundland suppliers urge regulators to block owner's exit strategy to prevent margin compression.
The Guardian
- Single source8 days agoUK Retail Restructuring
Rotherham high street struggles as shoppers flee to retail parks
British high streets face persistent decline as traditional retail gives way to low-value service businesses, raising questions about urban commercial viability.
The Guardian
- Single source8 days agoConsumer Brands & Retail
Wayfair sales surge 10% despite weak furniture demand
Wayfair reports 10% sales growth, gaining market share despite weak furniture demand.
CNBC
- Reported by 2 outlets8 days agoGLP-1 Drug Market
Novo lifts annual forecast on Wegovy pill sales surge
Novo Nordisk raises 2024 guidance on stronger-than-expected oral Wegovy sales.
MarketWatch · CNBC
- Single source9 days agoUK Retail Restructuring
Primark accelerates home delivery launch as earnings fall
Primark accelerates home delivery rollout by two years as profit declines pressure the retailer to diversify revenue.
The Guardian
- Single source9 days agoUK Retail Restructuring
Asda appoints former Morrisons chief executive David Potts
Asda appoints former Morrisons chief executive to lead growth strategy at the supermarket chain.
BBC News
- Single source11 days agoUK Retail Restructuring
Virgin Media O2 plans major workforce reduction
Virgin Media O2 to cut thousands of jobs, signaling cost pressure in UK telecoms.
BBC News
- Single source12 days agoUK Retail Restructuring
Oxfam retail profit drops 23% as online resale platforms erode charity shop sales
UK charity shop profits fall as secondhand clothing market shifts, pressuring retail fundraising.
The Guardian
- Single source14 days agoGLP-1 Drug Market
Analyst lifts Eli Lilly price target on obesity drug momentum
CNBC raises Eli Lilly price target on sustained obesity-drug demand.
CNBC
- Single source14 days agoUK Retail Restructuring
Poundland owner moves toward administration despite union plea, threatening 12,000 jobs
UK union urges intervention to prevent Poundland administration, threatening 12,000 jobs.
The Guardian
- Single source14 days agoGLP-1 Drug Market
Eli Lilly raises full-year guidance as Zepbound, Mounjaro sales accelerate
Eli Lilly beats earnings estimates and raises full-year sales guidance, citing strong demand for obesity drugs Zepbound and Mounjaro.
CNBC
- Single source15 days agoUK Retail Restructuring
UK business secretary contacts Poundland owner as collapse looms
UK business secretary contacts Poundland owner as administration risk mounts for the discount retailer.
The Guardian
- Single source15 days agoGLP-1 Drug Market
Traders wager against Chipotle ahead of earnings report
Traders are placing large bearish bets on a restaurant company ahead of earnings.
CNBC
- Single source16 days agoGLP-1 Drug Market
Employers drop GLP-1 weight-loss coverage as premiums climb
Employer health plans are dropping GLP-1 drug coverage ahead of 2027, narrowing weight-loss options for workers.
CNBC
- Single source16 days agoFood & Nutrition Policy
Retailers report surge in radio and canned food purchases following stockpiling warnings
Sales of radios, tinned foods, torches and power banks have spiked sharply, according to retail data obtained by BBC Newsnight.
BBC News
- Single source17 days agoGLP-1 Drug Market
Cramer: Tech insiders recommend biotech stock over AI plays
Cramer reports tech insiders recommend a drug stock as a buy, citing unnamed sources.
CNBC
- Single source17 days agoGLP-1 Drug Development
Moderna cancer vaccine enthusiasm wanes as Phase 3 data disappoints
Investor enthusiasm for Moderna's cancer vaccine candidate is waning.
MarketWatch
- Single source19 days agoGLP-1 Drug Development
Biotech rally draws investors seeking exposure to drug innovation wave
Biotech stocks are rising on optimism about new drug innovation.
CNBC
- Single source19 days agoGLP-1 Drug Development
Amgen drug reduces mortality 58% when paired with AstraZeneca immunotherapy
Amgen reports its drug combination reduces mortality risk by 58% in aggressive lung cancer patients.
CNBC
- Single source20 days agoGLP-1 Drug Market
Weight-loss drugs threaten beer sales, major brewer tells UK bars
Heineken warns UK pubs that weight-loss drug adoption will reduce beer consumption and pub visits.
The Guardian
- Single source21 days agoGLP-1 Drug Market
L'Oreal CEO cites weight loss drugs as drag on beauty sales
L'Oreal reports weight loss drugs are damaging beauty and skincare sales.
BBC News
- Single source23 days agoGLP-1 Drug Development
Novo's experimental obesity injection produces quarter bodyweight reduction in women
Novo disclosed that CagriSema, an experimental injection, achieved greater weight reduction than its existing Wegovy treatment in late-stage testing.
CNBC
- Single source27 days agoAlcohol Minimum Pricing
Lincolnshire pub owner cites television and discount alcohol as reasons for exit
UK pub landlord exits business citing competition from television and cheap alcohol retail, signaling sector pressure.
BBC News
- Single source29 days agoGLP-1 Drug Market
South Australia's inaugural Michelin-starred restaurants number eleven establishments
Michelin Guide awards inaugural stars to 11 Australian restaurants, signaling prestige dining market expansion in the region.
BBC News
- Single source30 days agoGLP-1 Drug Market
Walmart expands worker benefits to include free diabetes and respiratory medications
Walmart expands employee benefits to cover GLP-1 drugs, inhalers, and insulin at no cost.
CNBC
- Single sourceabout 1 month agoUK Retail Restructuring
Poundland seeks buyer as ownership explores rescue options
Poundland owners seek buyer in rescue talks, signaling distress in UK discount retail.
BBC News
- Single sourceabout 1 month agoFood & Nutrition Policy
Early sugar restriction may shape lifelong health outcomes, research indicates
Long-term health study of post-war sugar-rationed generation reveals dietary legacy effects decades later.
The Guardian
- Single sourceabout 1 month agoGLP-1 Drug Market
Butter experiences cultural resurgence as specialty shops and collectors embrace the dairy product
Global butter demand has surged, reversing a long decline in consumption of the dairy product.
The Guardian
- Single sourceabout 1 month agoGLP-1 Drug Market
Appetite-suppressing medications weigh on restaurant sales and traffic
Weight loss drugs reduce diner appetite, pressuring restaurant traffic and spending.
The New York Times
- Single sourceabout 1 month agoGLP-1 Drug Development
Eli Lilly and Novo Nordisk pursue amylin-based treatments for obesity
Eli Lilly and Novo Nordisk are developing amylin-based obesity drugs to follow their GLP-1 successes.
CNBC
- Single sourceabout 1 month agoSpirits Industry & Trade
English distillers gain protected status, angering Scottish rivals
U.K. government support for English whisky production is drawing criticism from Scottish whisky producers.
The New York Times
- Single sourceabout 1 month agoFood & Nutrition Policy
Scotland bans high-sugar products from supermarket end-of-aisle displays
Scotland implements new supermarket rules restricting cereal placement, likely limiting prominent end-of-aisle positioning.
BBC News
- Single sourceabout 1 month agoAlcohol Minimum Pricing
Wales raises minimum alcohol pricing by 30 percent
Minimum alcohol prices are rising, affecting consumer spending on beverages.
BBC News
- Single sourceabout 1 month agoGLP-1 Drug Development
Eli Lilly's dual-drug obesity treatment demonstrates stronger weight reduction in Phase 2
Eli Lilly's combination obesity treatment shows improved weight loss results in mid-stage trial.
CNBC
- Single sourceabout 1 month agoGLP-1 Drug Market
Novo Nordisk's oral obesity drug proves effective for patients transitioning from injections
Novo Nordisk's Wegovy oral formulation maintains weight-loss efficacy in real-world patients switching from injectable GLP-1 drugs.
CNBC
- Single sourceabout 1 month agoUK Retail Restructuring
Poundland leadership pursues buyout to protect thousands of positions
Poundland management enters rescue talks to preserve 11,000 jobs at the discount retailer.
The Guardian
- Single sourceabout 1 month agoFood & Nutrition Policy
British regulator prohibits Huel from advertising meal replacement as complete food substitute
The UK advertising authority blocked Huel's promotion after determining the ad implied its products could nutritionally replace all conventional meals.
BBC News